Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone Implants for Alcoholism
2011-002181-20Phase 3Terminated
- Sponsor
- Oslo University Hospital
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naltrexone in alcohol dependence and alcohol use disorder (AUD) (2 arms), sponsored by Oslo University Hospital. Primary endpoint: First day with heavy drinking. Started Jun 2011; status: terminated.
02
Drugs
naltrexone
03
Conditions
alcohol dependencealcohol use disorder (AUD)
Beyond the preview
Go deeper on 2011-002181-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002181-20.